Wassim Fares, Chief Medical Officer at Bellerophon Therapeutics, Inc. (BLPH), bought 4,000 shares at $10.18 ($41K) on 2020-09-10, disclosed to the SEC on 2020-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.